tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Cash flow

1,095 Followers

Fate Therapeutics Cash Flow

FATE's free cash flow for Q4 2023 was $-36.82M. For the 2023 fiscal year, FATE's free cash flow was decreased by $145.36M and operating cash flow was $-36.64M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -132.26M$ -132.26M$ -248.21M$ -162.82M$ -39.23M$ -83.17M
Investing Cash Flow
$ 112.67M$ 112.67M$ 166.75M$ -324.02M$ -161.08M$ -157.45M
Financing Cash Flow
$ 85.00K$ 85.00K$ 9.21M$ 453.13M$ 282.84M$ 149.93M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 224.68M$ 57.05M$ 76.56M$ 148.86M$ 182.57M$ 100.04M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----$ 0.00$ 2.29M
Issuance Of Capital Stock
---$ 411.74M$ 272.69M$ 162.41M
Issuance Of Debt
-----$ 0.00
Repayment Of Debt
----$ 0.00$ -15.00M
Free Cash Flow
$ -138.42M$ -138.42M$ -283.77M$ -213.52M$ -44.16M$ -90.57M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Fate Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis